Are you Dr. Gaber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
M227
Houston, TX 77030Phone+1 713-441-3883Fax+1 713-441-3886
Summary
- Dr. Lillian Gaber, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Tennessee, and Illinois. She is affiliated with Houston Methodist Hospital, Houston Methodist Sugar Land Hospital, and Houston Methodist Willowbrook Hospital.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1984 - 1985
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 1981 - 1984
Cairo University School of MedicineClass of 1976
Certifications & Licensure
TX State Medical License 2008 - 2025
TN State Medical License 1987 - 2011
IL State Medical License 1986 - 1987- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 2 citationsReproducibility and prognostic ability of chronicity parameters in kidney biopsy - Comprehensive evaluation comparing microscopy and artificial intelligence in digital...Rajesh Nachiappa Ganesh, Edward A Graviss, Duc Nguyen, Ziad El-Zaatari, Lillian Gaber
Human Pathology. 2024-04-01 - Myoglobin Cast Nephropathy Diagnosed on Renal Biopsy in a Patient Treated for Malarial Infection.Ramya Varadarajan, Ashmi Patel, Haneen Salah, Neil Sutaria, Roberto Barrios
Case Reports in Nephrology. 2024-01-01 - Vancomycin nephrotoxicity: A comprehensive clinico-pathological study.Rajesh Nachiappa Ganesh, Angelina Edwards, Ziad El Zaatari, Lillian Gaber, Roberto Barrios
Plos One. 2024-01-01
Press Mentions
N E W S O F T H E T E X a S M E D I C a L C E N T E R — v O L . 6 / N O. 1 1 , D E C . 2 0 1 9 — J a N . 2 0 2 0November 13th, 2019
